https://www.thebody.com/health/hiv-tivicay-dolutegravir
HIV MedicationsTivicay

Tivicay (Dolutegravir) for HIV Treatment: Everything You Need to Know

Tivicay Dolutegravir
Courtesy of ViiV Healthcare

    Frequently Asked QuestionsTivicay (Dolutegravir)

    What is Tivicay used for?

    Tivicay (and Tivicay PD for children) is a medication in the class of drugs called “integrase strand transfer inhibitors” (INSTIs), which stop HIV from making copies of itself later in its life cycle. Tivicay is used for the treatment of HIV in combination with one or more other drugs. It was approved by the U.S. Food and Drug Administration in 2013. In 2020, the FDA approved Tivicay PD for use in children at least 4 weeks old and weighing at least 6.6 pounds (3 kg). The generic name for Tivicay is dolutegravir.

    How often is Tivicay taken?

    Tivicay is normally taken at the same time every day. Some adults who are also taking certain other medications that affect Tivicay levels in the body (including some antacids and laxatives) may need to take it twice daily. Always follow your medical provider’s instructions for how and when to take Tivicay.

    Does Tivicay have any side effects I should worry about?

    Tivicay is usually very well tolerated. In clinical studies, the most common side effects of Tivicay were trouble sleeping, fatigue, and headache. A growing number of studies also show evidence of potential weight gain among those taking Tivicay. Tell your medical provider if you develop any side effects.

    Michael Broder

    Michael Broder

    Michael H. Broder is a same-sex-married, HIV-positive man of learning and letters living in Bed-Stuy, Brooklyn. He holds a PhD in classics from CUNY and an MFA in creative writing from NYU. His book of poems, This Life Now (A Midsummer Night's Press, 2014), was a finalist for a Lambda Literary Award. He is the publisher of Indolent Books, a small nonprofit poetry press, and founder of the HIV Here & Now poetry project.